[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100507586":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":10,"centralContacts":29,"locations":35,"responsibleParty":50,"collaborators":52,"id":55,"slug":10,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":59,"acronym":10,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":10,"enrollmentInfo":63,"targetDuration":10,"studyType":66,"phases":10,"briefSummary":67,"conditions":68,"keywords":10,"overallStatus":37,"whyStopped":10,"lastUpdateSubmitDate":73,"lastUpdatePostDateStruct":74,"startDateStruct":77,"completionDateStruct":79,"leadSponsor":81,"locationsCount":82},{"fullName":5,"class":6},"Guy's and St Thomas' NHS Foundation Trust","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Non-small cell lung cancer",null,"NSCLC",[13],"Diagnostic Test: 18F-FSPG PET\u002FCT in NSCLC",{"label":15,"type":10,"description":16,"interventionNames":17},"Head and neck squamous cell cancer","HNSCC",[18],"Diagnostic Test: 18F-FSPG PET\u002FCT in HNSCC",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":10},"DIAGNOSTIC_TEST","18F-FSPG PET\u002FCT in NSCLC","Stage 3 NSCLC with radical curative intent at baseline (pre-treatment) and at 4-8 weeks into treatment.",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":10},"18F-FSPG PET\u002FCT in HNSCC","Stage 3 and 4 HNSCC with radical curative intent at baseline and at 2-4 weeks into treatment.",[15],[30],{"name":31,"role":32,"phone":33,"phoneExt":10,"email":34},"Gark Cook","CONTACT","0207 188 8364","gary.cook@kcl.ac.uk",[36],{"facility":5,"status":37,"city":38,"state":10,"zip":10,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"RECRUITING","London","United Kingdom","UK",{"type":42,"coordinates":43},"Point",[44,45],-0.12574,51.50853,{"lat":45,"lon":44},[48],{"name":49,"role":32,"phone":10,"phoneExt":10,"email":10},"Gary Cook",{"type":51,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[53],{"name":54,"class":6},"King's College London","100507586",false,"NCT05889312","Assessing Cancer Treatment Response to Therapy Using 18F-FSPG PET","Improving Response Assessment in Cancer by Measurement of Cellular Redox Status Using 18F-FSPG Positron Emission Tomography","Inclusion Criteria:\n\n1. Written informed consent\n2. Aged 16 or above\n3. Histologically confirmed HNSCC or NSCLC, who are treatment naïve and scheduled to commence standard of care treatment ((chemo)radiotherapy)\n4. Willingness and ability to comply with scheduled study visits and tests\n5. Confirmation of adequate function of all major organs and systems\n\nExclusion Criteria:\n\n1. Pregnant or lactating women\n2. Concomitant uncontrolled medical conditions\n3. Participants likely to require palliative radiotherapy within the first 12 weeks of treatment\n4. Prognosis less than 3 months\n5. Previous anti-cancer treatment (only treatment naïve patients eligible for inclusion)","ALL","16 Years",{"count":64,"type":65},32,"ESTIMATED","OBSERVATIONAL","Prospective single centre non-randomised exploratory observational study to measure changes in tumour cellular redox status with 18F-FSPG PET in stage 3 non-small cell lung cancer (NSCLC) and stage 3 and 4 head and neck squamous cell cancer (HNSCC) at baseline and during standard of care treatment, and to compare this with 18F-FDG PET\u002FCT and RECIST 1.1 response at 12 weeks.",[69,70,71,72],"Cancer","Diagnosis","Resistant Cancer","Response, Acute Phase","2025-04-02",{"date":75,"type":76},"2025-04-04","ACTUAL",{"date":78,"type":76},"2025-02-19",{"date":80,"type":65},"2027-09",{"name":5,"class":6},1]